Virginia
Colorectal cancer clinical trials in Virginia
98 colorectal cancer studies are recruiting participants at sites in 34 cities across Virginia as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Virginia city with a recruiting study
Fairfax (62), Richmond (20), Charlottesville (15), South Hill (8), Roanoke (7), Midlothian (6), Mechanicsville (5), Norfolk (5), Lynchburg (4), Arlington (3), Salem (3), Winchester (3), Woodbridge (3), Blacksburg (2), Burke (2), Chesapeake (2), Fishersville (2), Fredericksburg (2), Martinsville (2), McLean (2), Newport News (2), Virginia Beach (2), Williamsburg (2), Gloucester (1), Low Moor (1), Manassas (1), Orange (1), Petersburg (1), Portsmouth (1), Raonoke (1), Reston (1), Suffolk (1), Tappahannock (1), Wytheville (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Recently updated studies in Virginia
Basic details from each study's public record (the 12 most recently updated of 98). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Recruiting in
- Fairfax
- Registry record
- NCT06324357 · updated
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- Tyligand Pharmaceuticals (Suzhou) Limited
- Recruiting in
- Fairfax
- Registry record
- NCT06385925 · updated
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 to 99
- All sexes
- Sponsor
- Erasca, Inc.
- Recruiting in
- Fairfax
- Registry record
- NCT06983743 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Recruiting in
- Fairfax
- Registry record
- NCT07488676 · updated
A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- SOTIO Biotech a.s.
- Recruiting in
- Fairfax
- Registry record
- NCT07693751 · updated
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pliant Therapeutics, Inc.
- Recruiting in
- Fairfax
- Registry record
- NCT06270706 · updated
Shield Post-Approval Study Protocol
- Observational
- Ages 45 to 81
- All sexes
- Sponsor
- Guardant Health, Inc.
- Recruiting in
- Williamsburg
- Registry record
- NCT06880055 · updated
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Charlottesville · Fairfax
- Registry record
- NCT06997497 · updated
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kestrel Therapeutics, Inc.
- Recruiting in
- Fairfax
- Registry record
- NCT07458347 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Recruiting in
- Charlottesville · Fairfax
- Registry record
- NCT07659795 · updated
A KRAS Inhibitor in Participants With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Ensem Therapeutics
- Recruiting in
- Fairfax
- Registry record
- NCT07912593 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Recruiting in
- Charlottesville · Fairfax
- Registry record
- NCT07020221 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Virginia on ClinicalTrials.gov.
Ask about studies in Virginia
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections